LSB
Price
$2.72
Change
+$0.37 (+15.74%)
Updated
Jan 17 closing price
Capitalization
51.96M
SKYE
Price
$2.66
Change
-$0.04 (-1.48%)
Updated
Jan 17 closing price
Capitalization
80.7M
Ad is loading...

LSB vs SKYE

Header iconLSB vs SKYE Comparison
Open Charts LSB vs SKYEBanner chart's image
LakeShore Biopharma
Price$2.72
Change+$0.37 (+15.74%)
Volume$13.25K
Capitalization51.96M
Skye Bioscience
Price$2.66
Change-$0.04 (-1.48%)
Volume$44.69K
Capitalization80.7M
LSB vs SKYE Comparison Chart
Loading...
SKYE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LSB vs. SKYE commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LSB is a Hold and SKYE is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (LSB: $2.72 vs. SKYE: $2.66)
Brand notoriety: LSB and SKYE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LSB: 59% vs. SKYE: 26%
Market capitalization -- LSB: $51.96M vs. SKYE: $80.7M
LSB [@Biotechnology] is valued at $51.96M. SKYE’s [@Biotechnology] market capitalization is $80.7M. The market cap for tickers in the [@Biotechnology] industry ranges from $352.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LSB’s FA Score shows that 1 FA rating(s) are green whileSKYE’s FA Score has 0 green FA rating(s).

  • LSB’s FA Score: 1 green, 4 red.
  • SKYE’s FA Score: 0 green, 5 red.
According to our system of comparison, both LSB and SKYE are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SKYE’s TA Score shows that 4 TA indicator(s) are bullish.

  • SKYE’s TA Score: 4 bullish, 3 bearish.

Price Growth

LSB (@Biotechnology) experienced а -11.59% price change this week, while SKYE (@Biotechnology) price change was -3.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.65%, and the average quarterly price growth was -1.89%.

Reported Earning Dates

SKYE is expected to report earnings on Nov 29, 2023.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SKYE($80.7M) has a higher market cap than LSB($52M). SKYE YTD gains are higher at: -6.007 vs. LSB (-21.301). SKYE has higher annual earnings (EBITDA): -19.64M vs. LSB (-220.1M). SKYE has more cash in the bank: 67.4M vs. LSB (49.5M). SKYE has less debt than LSB: SKYE (191K) vs LSB (369M). LSB has higher revenues than SKYE: LSB (672M) vs SKYE (0).
LSBSKYELSB / SKYE
Capitalization52M80.7M64%
EBITDA-220.1M-19.64M1,121%
Gain YTD-21.301-6.007355%
P/E RatioN/A5.02-
Revenue672M0-
Total Cash49.5M67.4M73%
Total Debt369M191K193,194%
FUNDAMENTALS RATINGS
SKYE: Fundamental Ratings
SKYE
OUTLOOK RATING
1..100
4
VALUATION
overvalued / fair valued / undervalued
1..100
37
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
91
P/E GROWTH RATING
1..100
94
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SKYE
RSI
ODDS (%)
Bullish Trend 5 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
90%
Momentum
ODDS (%)
Bullish Trend 5 days ago
89%
MACD
ODDS (%)
Bullish Trend 5 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
90%
Advances
ODDS (%)
Bullish Trend 11 days ago
86%
Declines
ODDS (%)
Bearish Trend 26 days ago
90%
BollingerBands
ODDS (%)
N/A
Aroon
ODDS (%)
Bearish Trend 5 days ago
90%
View a ticker or compare two or three
Ad is loading...
SKYE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA426.5012.68
+3.06%
Tesla
SPY597.585.94
+1.00%
SPDR® S&P 500® ETF Trust
AAPL229.981.72
+0.75%
Apple
BTC.X104408.070000-53.968750
-0.05%
Bitcoin cryptocurrency
GME27.51-0.21
-0.76%
GameStop Corp

LSB and

Correlation & Price change

A.I.dvisor tells us that LSB and APM have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LSB and APM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LSB
1D Price
Change %
LSB100%
+16.12%
APM - LSB
26%
Poorly correlated
-3.36%
GLTO - LSB
24%
Poorly correlated
+10.78%
SKYE - LSB
20%
Poorly correlated
-1.48%
CERO - LSB
13%
Poorly correlated
-6.02%
QTTB - LSB
13%
Poorly correlated
+4.46%
More

SKYE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SKYE has been loosely correlated with JANX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if SKYE jumps, then JANX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SKYE
1D Price
Change %
SKYE100%
-1.48%
JANX - SKYE
38%
Loosely correlated
+0.27%
VKTX - SKYE
36%
Loosely correlated
+0.28%
ABCZF - SKYE
29%
Poorly correlated
N/A
DNLI - SKYE
27%
Poorly correlated
+1.20%
PGEN - SKYE
26%
Poorly correlated
N/A
More